MRD / Regn No. : SG002757 Date : 20/07/2026
Patient Name : MD Shaazada Age & Gender : 62 Yrs. / Male
Contact No. : 9681462499 UHID :
Ht / Wt / BMI : 166 / 72 / 26.13 BP S / BP D : 169 / 99
Allergies : NKA Referred By :
   
Problem List : TYPE 2 DIABETES (27/Jul/2004) | HYPERTENSION (27/Jul/2024) |
Salient Investigations : CREATININE: 0.9 | EGFR EGLOMERULAR FILTRATION RATE: 91.07 mL/min/1.73m2 | FASTING PLASMA GLUCOSE (FPG): 300 mg/dL | LDL LOW DENSITY LIPOPROTEIN: 105 mg/dL
S# Generic (Trade) Name Route Dosage Usage Duration
1 TABLET TELMISARTAN 40 MG + AMLODIPINE 5 MG
APEL AM 		PO 1-0-0 BEFORE BREAKFAST
 TILL NEXT VISIT
2 TABLET ROSUVASTATIN 20 MG
STATEZE R 20 		PO 0-0-1 BEFORE DINNER
3 TABLET TAMULOSIN 0.4 MG DUTASERIDE 0.5 MG
URIMAX D
Medicine For MAY CAUSE ERECTILE DYSFUNCTION OR LOSS OF LIBIDO 		PO 0-0-1 BEFORE DINNER
 TILL NEXT VISIT
MAY CAUSE ERECTILE DYSFUNCTION OR LOSS OF LIBIDO
4 ANTIHYPERGLYCEMIC DAPAGLIFLOZIN 10 MG + METFORMIN 1000 SR
APDA M FORTE 		PO 1-0-0 BEFORE BREAKFAST
 TILL NEXT VISIT
5 INJECTION DEGLUDEC / ASPART (INJ U100) 70/30
RYZODEG
Medicine For DIABETES 		SQ 30-0-24 BEFORE BREAKFAST AND DINNER
 TILL NEXT VISIT
MAY CAUSE HYPOGLYCEMIA
6 ANTIHYPERGLYCEMIC SEMAGLUTIDE 0.25 MG
SEMAGLU 0.25 MG 		SC ONCE A WEEK AFTER BREAKFAST
 TILL NEXT VISIT
7 PREGABALIN 150 MG
LYRICA 150 MG 		PO 0-0-1 BEFORE DINNER
 TILL NEXT VISIT
       
Refill : 0 / Substitution:    
Education :
Next Visit : 20/Jan/2027
Tests Suggested For Next Visit : SMBG,HBA1C-HPLC METHOD,UACR:SPOT SAMPLE,RETINA CHECK UP
   
   
User-Profile-Image
Dr. Samit Ghosal
MD (GM), Diploma in Diabetes Cardiff University, MSc (Diabetes Care) Glamorgan University, Diploma in Endocrinology Glamorgan University (USW), SCOPE certification in obesity management
West Bengal / 54020

This is a Computer generated Prescription

Powered By: